20 June 2013
Keywords: elan, completes, sales, myobloc, solstice, neurosciences, irish
Article | 12 July 2004
Irish drugmaker Elan Corp has completed the sale of its worldwiderights to Myobloc/Neurobloc (botulinum toxin type B) injectable
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 November 2004
19 June 2013
© 2013 thepharmaletter.com